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A 32-year-old man, with a medical history notable only for severe hypertension, was
referred to our hospital for hydrocephaly, secondary to a voluminous, hypervascularized,
right tympanic tumour encasing the jugular vein and extending to the posterior fossa
(Fig. 1A).
On admission, the patient was dyspnoeic. Blood pressure was 180/93mmHg and heart
rate was 117 beats/min. Plasma brain natriuretic protein concentration was 2200 pg/mL.
Echocardiography showed left ventricular (LV) dilatation (end-diastolic diameter 70mm)
and non-obstructive global LV hypertrophy (LV mass index 200 g/m2). LV ejection fraction
was 30%. These ﬁndings were conﬁrmed by magnetic resonance imaging (MRI; Videos 1 and
2), which also demonstrated cardiac ﬁbrosis (Fig. 2). Because of the presence of both a
tumour and hypertrophic cardiomyopathy, metaiodobenzylguanidine (MIBG) and octreotide
scintigraphy were performed. These showed high ﬁxation of the tumour, consistent with
a paraganglioma (Fig. 1B). No other tumour foci were identiﬁed. Urine analysis conﬁrmed
catecholamine levels ﬁve to 10 times normal values and genetic testing demonstrated a
characteristic mutation for paraganglioma (SDHC gene).
Unfortunately, because of the location and extensive size of the tumour, only palliative
treatment for hydrocephaly with a ventriculoperitoneal shunt, andmedical therapy for car-
diomyopathy with alpha- and beta-adrenergic blockers, were pursued. Genetic screening
was proposed to the patient’s family.
The prevalence of paraganglioma is one in 30,000; 30% of patients have a genetic sub-
strate and 10% of tumours secrete catecholamines. The diagnosis is established by MIBG
or octreotide scintigraphy; biopsies are not indicated. MRI and computed tomography
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Figure 1. Panel A: cerebral magnetic resonance imaging, T1-weighted, axial and coronal views, showing the tumour with compression of
the brain stem and extension to the posterior fossa. Panel B: metaiodobenzylguanidine scintigraphy showing the high ﬁxation of the tumour,
consistent with a paraganglioma.
Figure 2. Cardiac magnetic resonance imaging. Panel A: parasternal long-axis view of the left ventricle showing its dilatation and global
hypertrophy. Panel B: phase-sensitive infrared single-shot sequence showing linear and nodular intramyocardial enhancement (arrows),
consistent with non-ischaemic pattern of myocardial ﬁbrosis.
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determine tumour extension and vascularization to guide
treatment: embolization, surgery and/or metabolic
radiotherapy. Severe hypertension in a young sub-
ject, especially if associated with cardiac function
impairment and hypertrophy, justiﬁes exhaustive inves-
tigations looking for an extracardiovascular aetiology,
whereas any patient with a known tumour such as
paraganglioma or pheochromocytma should undergo
complete cardiac examination before any surgical
treatment.
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